IRIS
ODDO, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.481
NA - Nord America 2.602
AS - Asia 1.795
SA - Sud America 580
Continente sconosciuto - Info sul continente non disponibili 148
AF - Africa 58
OC - Oceania 9
Totale 8.673
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.519
RU - Federazione Russa 2.096
SG - Singapore 822
IE - Irlanda 496
BR - Brasile 493
CN - Cina 314
HK - Hong Kong 299
SE - Svezia 295
IT - Italia 183
FR - Francia 127
IN - India 87
DE - Germania 80
VN - Vietnam 62
BD - Bangladesh 47
NL - Olanda 39
CA - Canada 38
AR - Argentina 36
GB - Regno Unito 35
FI - Finlandia 26
ZA - Sudafrica 23
AT - Austria 21
JP - Giappone 20
PL - Polonia 20
MX - Messico 16
PK - Pakistan 16
TR - Turchia 16
EC - Ecuador 15
ES - Italia 13
IQ - Iraq 12
MY - Malesia 11
UA - Ucraina 11
ID - Indonesia 10
CO - Colombia 9
EU - Europa 9
MA - Marocco 9
SA - Arabia Saudita 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
CZ - Repubblica Ceca 7
PH - Filippine 7
PY - Paraguay 7
TH - Thailandia 7
TN - Tunisia 7
EG - Egitto 6
LT - Lituania 6
UZ - Uzbekistan 6
CL - Cile 5
JM - Giamaica 5
KE - Kenya 5
BE - Belgio 4
DO - Repubblica Dominicana 4
JO - Giordania 4
KR - Corea 4
NP - Nepal 4
PE - Perù 4
TW - Taiwan 4
BB - Barbados 3
DK - Danimarca 3
ET - Etiopia 3
IL - Israele 3
KW - Kuwait 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NI - Nicaragua 3
PT - Portogallo 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CH - Svizzera 1
CR - Costa Rica 1
FJ - Figi 1
GN - Guinea 1
HT - Haiti 1
HU - Ungheria 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 8.533
Salva come PNG Salva come JPEG
Città #
Moscow 587
Dublin 496
Ashburn 493
Singapore 444
Hong Kong 298
Nyköping 277
Dallas 260
San Jose 251
Council Bluffs 156
The Dalles 127
Lauterbourg 88
Los Angeles 88
Chandler 86
Princeton 86
Medford 85
Des Moines 66
Messina 59
Pune 48
Buffalo 43
Beijing 42
Redondo Beach 39
São Paulo 36
Tianjin 36
Brooklyn 31
Santa Clara 30
Munich 29
Ho Chi Minh City 27
New York 27
Rio de Janeiro 25
Orem 24
Boardman 20
Guangzhou 20
Nuremberg 19
Tokyo 19
Columbus 18
Montreal 17
Warsaw 15
Amsterdam 14
Wilmington 14
Frankfurt am Main 13
Johannesburg 13
Atlanta 12
Phoenix 12
San Francisco 12
Turku 12
Vienna 12
Chennai 11
Dhaka 11
Hanoi 11
Rome 11
Shanghai 10
Shenzhen 10
Belo Horizonte 9
Denver 9
Porto Alegre 9
Stockholm 9
Catania 8
Chicago 8
Düsseldorf 8
Guarulhos 8
Jiaxing 8
Boston 7
Brno 7
Campinas 7
Jinan 7
Palermo 7
Toronto 7
Charlotte 6
Goiânia 6
Hyderabad 6
Lappeenranta 6
London 6
Ningbo 6
Baghdad 5
Helsinki 5
Manchester 5
Mumbai 5
Norwalk 5
Poplar 5
Recife 5
Salvador 5
São Bernardo do Campo 5
Tashkent 5
Amman 4
Ankara 4
Araras 4
Augusta 4
Belford Roxo 4
Bexley 4
Cape Town 4
Casablanca 4
Curitiba 4
Istanbul 4
Joinville 4
Kuala Lumpur 4
Lahore 4
Manaus 4
Mexico City 4
Miami 4
Nanjing 4
Totale 4.962
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 341
A Novel Serum-Based Diagnosis of Alzheimer's Disease Using an Advanced Phage-Based Biochip 203
Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders 172
ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD 136
Multipotential Role of Growth Factor Mimetic Peptides for Osteochondral Tissue Engineering 134
Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice 127
The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities 124
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer‘s disease 124
BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer‘s Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology 123
Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders 122
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice 122
An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease 121
Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease 119
Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease 119
Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aß oligomers accumulation 117
Physiologic Response Evaluation of Human Foetal Osteoblast Cells within Engineered 3D-Printed Polylactic Acid Scaffolds 116
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome 115
Generation of a Biotin-Tagged Dual-Display Phage 112
Alzheimer's disease: Abeta, tau and synaptic dysfunction 111
Autophagic/lysosomal dysfunction in Alzheimer's disease 109
Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification 108
Administration of a selective beta 2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease 105
Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits 105
Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canine 102
Maternal choline supplementation ameliorates Alzheimer's disease pathology by reducing brain homocysteine levels across multiple generations 102
A dynamic relationship between intracellular and extracellular pools of Abeta 101
Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer‘s disease 97
Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology 93
Necroptosis activation in Alzheimer's disease 91
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? 91
The ubiquitin-proteasome system in Alzheimer‘s disease 89
Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer‘s disease 86
Generation of a helper phage for the fluorescent detection of peptide-target interactions by dual-display phages 82
beta(2) Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models 81
PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD 79
mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease 79
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology 78
Intracellular amyloid-beta in Alzheimer‘s disease 76
Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle 76
Silicon‐Based Sensing Surface for Alzheimer's Disease Diagnosis by Phages Probes 76
Innovative Silicon-Based Sensing Strategy for the Alzheimer’s Disease Detection by Phage Display 75
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology 75
Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43 74
Increased intraneuronal resting [Ca2+] in adult Alzheimer‘s disease mice 74
Genetic suppression of beta 2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies 74
Engineered phage-silver nanoparticle complexes as a new tool for targeted therapies 73
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease 72
Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice 72
Triple-transgenic model of Alzheimer‘s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction 72
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer‘s disease 72
Dyrk1 inhibition improves Alzheimer's disease-like pathology 72
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice 71
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer‘s disease mice 71
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits 71
Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice 71
Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles 70
Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice 70
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study 69
Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease 68
M1 receptors play a central role in modulating AD-like pathology in transgenic mice 68
Validation of a 2-day water maze protocol in mice 67
Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice 66
Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice 66
Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer‘s disease 66
Modeling behavioral and neuronal symptoms of Alzheimer‘s disease in mice: a role for intraneuronal amyloid 66
Inhibition of soluble TNF signaling in a mouse model of Alzheimer‘s disease prevents pre-plaque amyloid-associated neuropathology 65
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease 65
Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles 65
Congo red and thioflavin-T analogs detect Abeta oligomers 64
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer‘s disease progression 64
Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia 64
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature 64
Intraneuronal Abeta causes the onset of early Alzheimer‘s disease-related cognitive deficits in transgenic mice 64
Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease 63
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer‘s disease 63
Identification of learning-induced changes in protein networks in the hippocampi of a mouse model of Alzheimer's disease 63
Glucocorticoids Exacerbate Cognitive Deficits in TDP-25 Transgenic Mice via a Glutathione-Mediated Mechanism: Implications for Aging, Stress and TDP-43 Proteinopathies 62
Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism 61
Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology 60
The Collagen Chaperone HSP47 Is a New Interactor of APP that Affects the Levels of Extracellular Beta-Amyloid Peptides 60
Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer‘s mouse models 60
Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology 59
Oxidative Damage and Amyloid-beta Metabolism in Brain Regions of the Longest-Lived Rodents 59
CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer‘s disease 59
Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease 59
Neural stem cells improve memory in an inducible mouse model of neuronal loss 59
The role of nicotinic acetylcholine receptors in Alzheimer‘s disease 58
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story 58
The role of mTOR signaling in Alzheimer disease 58
Sortilin is required for toxic action of Aβ oligomers (AβOs): Extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways 58
Life-long rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and NMDA signaling 58
Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments 57
Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer‘s disease 57
Toxic role of K+ channel oxidation in mammalian brain 56
Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice 56
Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease 55
mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies 54
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease 54
Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity 53
Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability 52
Totale 8.415
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.606
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022317 0 0 0 1 5 4 41 22 5 0 3 236
2022/20231.021 107 67 48 22 36 100 21 47 544 4 20 5
2023/2024388 5 26 13 103 9 57 0 10 22 22 27 94
2024/20251.695 12 26 29 40 188 32 68 155 537 107 192 309
2025/20264.895 251 271 287 291 385 1.126 716 571 548 271 111 67
2026/2027256 81 175 0 0 0 0 0 0 0 0 0 0
Totale 8.673